Cyclerion Therapeutics In... (CYCN)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.00
0.08 (2.74%)
At close: Jan 15, 2025, 3:59 PM
3.01
0.40%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
Net Income | -5.26M | -44.08M | -51.65M | -77.80M | -123.01M | -115.25M | -93.92M | -63.55M |
Depreciation & Amortization | n/a | 65.00K | 472.00K | 2.30M | 2.70M | 1.53M | 1.75M | 2.17M |
Stock-Based Compensation | 1.07M | 6.25M | 9.61M | 14.99M | 19.63M | 12.43M | 9.49M | n/a |
Other Working Capital | -2.92M | -4.00M | 988.00K | -3.49M | 2.61M | 2.81M | 1.07M | 3.82M |
Other Non-Cash Items | -12.45M | 5.24M | 881.00K | -1.67M | 751.00K | 14.51M | 12.59M | 11.02M |
Deferred Income Tax | n/a | -5.24M | 2.76M | -2.72M | n/a | n/a | n/a | n/a |
Change in Working Capital | -4.60M | -2.85M | 1.41M | -7.59M | -2.29M | 3.79M | 1.47M | 4.33M |
Operating Cash Flow | -21.25M | -40.61M | -36.52M | -72.49M | -102.22M | -97.50M | -81.22M | -49.87M |
Capital Expenditures | n/a | n/a | -7.00K | -1.52M | -6.89M | -3.44M | -1.40M | -1.45M |
Acquisitions | n/a | n/a | 1.46M | 1.54M | 173.00K | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 10.40M | n/a | 1.46M | 1.54M | 173.00K | n/a | n/a | n/a |
Investing Cash Flow | 10.40M | n/a | 1.46M | 18.00K | -6.71M | -3.44M | -1.40M | -1.45M |
Debt Repayment | n/a | n/a | n/a | 3.51M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5.02M | 29.00K | 282.00K | 331.00K | 36.57M | 100.94M | 82.62M | 51.32M |
Financial Cash Flow | 5.02M | 29.00K | 30.79M | 28.09M | 211.57M | 100.94M | 82.62M | 51.32M |
Net Cash Flow | -5.81M | -40.58M | -4.27M | -44.39M | 102.62M | n/a | n/a | n/a |
Free Cash Flow | -21.25M | -40.61M | -36.52M | -74.01M | -109.10M | -100.94M | -82.62M | -51.32M |